Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a life-threatening
complication caused by platelet activation via platelet factor 4 (PF4) antibodies. We report a …

The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus (SARS-CoV-2) stimulated the development of highly effective …

Introduction: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare yet
severe adverse complication first identified during the global vaccination effort against SARS …

Summary The coronavirus disease 2019 (Covid‐19) pandemic has had devastating effects
on public health worldwide, but the deployment of vaccines for Covid‐19 protection has …

Vaccine-induced immune thrombotic thrombocytopenia (VITT), a potentially fatal syndrome
characterized by aggressive thrombosis, has recently been linked to two adenovirus vector …

The arrival of vaccination was a huge step in the prevention of COVID‑19, and significantly
decreased mortality and morbidity. However, with the large number of vaccine doses …

The development of vaccines to fight COVID-19 has been a remarkable medical
achievement. However, this global immunization effort has been complicated by a rare …

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a serious and life-
threatening complication occurring after adenovirus-vector COVID-19 vaccines, and is rarely …

Vaccine-induced immune thrombotic thrombocytopenia (VITT) has been reported in
association with the coronavirus disease 2019 preventative adenovirus vector-based …

Objectives Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a new and rare
syndrome resulting from the largest vaccination campaign against SARS-CoV-2 in the …